CMPS vs PACS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jul 29, 2026

CMPS

49.0
AI Score
VS
PACS Wins

PACS

49.9
AI Score

Investment Advisor Scores

CMPS

49score
Recommendation
HOLD

PACS

50score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CMPS PACS Winner
Net Income 91.20M 191.54M PACS
Operating Income -42.90M 309.60M PACS
ROE 27.9% 20.2% CMPS
ROA 17.2% 3.4% CMPS
Total Assets 531.74M 5.58B PACS
Cash 466.01M 197.02M CMPS
Debt/Equity 0.15 0.37 CMPS
Current Ratio 3.32 1.07 CMPS

Relative Price Performance (Last 90 Days)

CMPS 1M: -14.6% · 3M: +25.3% PACS 1M: +3.8% · 3M: +37.1%

Current Technical Phase

CMPS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 43

RSI (14): 42.6 · Price: $11.35

PACS

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (10.9% over 20 days), RSI 60

RSI (14): 59.6 · Price: $46.01

Fundamentals Snapshot

Metric CMPS PACS
Market Cap
Forward P/E -8.5 18.8
Trailing P/E 29.9
Revenue (TTM)
Revenue Growth 0.0% 0.1%
Gross Margin 0.2%
Operating Margin 0.0% 0.1%
EPS -3.14 1.57
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, PACS is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.